News

Volcanics Venture Has Moved Into a New Office!

We’re excited to announce that Volcanics Venture has officially moved into our brand-new office. From a team of just a few to a group of...

1 min read

The group standard "Sulfide Solid Electrolyte for Solid-State Lithium Batteries" formulated by Firmli Tech was approved

On November 20, 2024, the 26th Director's Office Meeting of the "Standardization Working Committee of the China Electronics Society" was...

2 min read

Triastek announced that it has entered into a research collaboration and platform technology license agreement with BioNTech SE

NANJING, China, July 23, 2024 – Triastek, Inc. ("Triastek"), a global leader in 3D printing pharmaceuticals, today announced that it has...

2 min read

Volcanics Venture warmly congratulates Fangzhou on its listing on the Hong Kong Stock Exchange

On July 9, Fangzhou Inc (06086.HK) , a member company of Volcanics Venture and "China's largest online chronic disease management...

3 min read

GJS Robot Shines at the Shenzhen Hi-Tech Fair

From November 15th to 19th, the 25th China International High-Tech Fair, themed 'Stimulating Innovation Vitality and Enhancing...

1 min read

GeeTest Wins Multiple Industry Awards Recognizing Corporate and Innovation Achievements

GeeTest, the leading bot management vendor and the creator of the Slide-CAPTCHA, proudly announces its success in the bot mitigation and...

2 min read

Phanes Therapeutics Announces Clinical Supply Agreement with BeiGene

Phanes Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate PT199 in combination with Tislelizumab.

3 min read

XLement product won the "Excellent Product Award" at CHTF 2022

WeSPR One micro-biomolecular Interaction Analyzer developed by XLement won the "Excellent Product Award"at CHTF 2022, stood out from more...

1 min read

火山石投资成员企业「方舟健客」冲刺港交所：中国最大线上慢病管理平台

2021年每名付费用户的平均消费金额为766.3元。

2 min read

Phanes Therapeutics' PT217 receives Orphan Drug Designation for small cell lung cancer from the FDA

Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research and clinical development in oncology, announced...

2 min read

Volcanics Venture awarded with "The Most Entrepreneur Friendly Investment Institution"

36Kr Venture Capital Research Institute, along with the “X·36under36” S-level young entrepreneurs launched in early June, launched a...

1 min read

Phanes Therapeutics announces FDA IND clearance for PT199

Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research and clinical development in immuno-oncology...

2 min read

Fourier Intelligence has received 400million in Series D funding led by SoftBank.

The Shanghai-based medtech business has received RMB 400million (£46.9million) in Series D funding, led by SoftBank Vision Fund 2 and...

1 min read

Volcanics Venture awarded with "Top100 Venture Capital Institutions in China "

Since 2001, Zero2IPO Research Center has published the annual ranking of China's equity investment for 21 consecutive years, adhering to...

1 min read

Volcanics Venture won multiply awards

Volcanics Venture awarded with "Top 100 Most Popular Investment Institutions for Entrepreneurs in China" by 36Kr, "China's Most Admired...

1 min read

Fourier Intelligence Raises Tens of Millions in Series C+ Financing Round

Tech company Fourier Intelligence receives tens of millions in a new round of financing to accelerate the construction of the...

2 min read

RootPath raises $50m

RootPath Genomics, a preclinical-stage biotech firm that develops personalised immunotherapy and cell therapy for solid tumours, has...

1 min read

Huleen, a note-taking mobile app, received the angel round funding from Volcanics Venture to further

Originally witten in Chinese by Wang Zhichen Source: kouailiyu (Wechat ID: akuailiyu) Recently, Huleen announced the closing of angel...

3 min read

Triastek Closes US$ 50 Million Series B Financing

Original from prnasia NANJING, China, June 24, 2021 /PRNewswire/ -- Triastek, Inc. (Triastek), a global leader in 3D printed...

3 min read